Isolation and structural characterization of a new fibrin(ogen)olytic metalloproteinase from Bothrops moojeni snake venom


Autoria(s): BERNARDES, Carolina P.; SANTOS-FILHO, Norival A.; COSTA, Tassia R.; GORNES, Mario S. R.; TORRES, Fernanda S.; COSTA, Junia; BORGES, Marcia H.; RICHARDSON, Michael; SANTOS, Daniel M. dos; PIMENTA, Adriano M. de Castro; HOMSI-BRANDEBURGO, Maria I.; SOARES, Andreimar M.; OLIVEIRA, Fabio de
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

A proteinase, named BmooMP alpha-I, from the venom of Bothrops moojeni, was purified by DEAE-Sephacel, Sephadex G-75 and heparin-agarose column chromatography. The enzyme was purified to homogeneity as judged by its migration profile in SDS-PAGE stained with coomassie blue, and showed a molecular mass of about 24.5 kDa. Its complete cDNA was obtained by RT-PCR and the 615 bp codified for a mature protein of 205 amino acid residues. The multiple alignment of its deduced amino acid sequence and those of other snake venom metalloproteinases showed a high structural similarly, mainly among class P-IB proteases. The enzyme cleaves the A alpha-chain of fibrinogen first, followed by the B beta-chain, and shows no effects on the gamma-chain. On fibrin, the enzyme hydrolyzed only the beta-chain, leaving the gamma-dimer apparently untouched. It was devoid of phospholipase A(2), hemorrhagic and thrombin-like activities. Like many venom enzymes, it is stable at pH values between 4 and 10 and stable at 70 degrees C for 15 min. The inhibitory effects of EDTA on the fibrinogenolytic activity suggest that BmooMP alpha-I is a metalloproteinase and inhibition by beta-mercaptoethanol revealed the important role of the disulfide bonds in the stabilization of the native structure. Aprotinin and benzamidine, specific serine proteinase inhibitors, had no effect on BmooMP alpha-I activity. Since the BmooMP alpha-I enzyme was found to cause defibrinogenation when administered i.p. on mice, it is expected that it may be of medical interest as a therapeutic agent in the treatment and prevention of arterial thrombosis. (C) 2007 Elsevier Ltd. All rights reserved.

Identificador

TOXICON, v.51, n.4, p.574-584, 2008

0041-0101

http://producao.usp.br/handle/BDPI/20291

10.1016/j.toxicon.2007.11.017

http://dx.doi.org/10.1016/j.toxicon.2007.11.017

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

Relação

Toxicon

Direitos

restrictedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #Bothrops moojeni #snake venom #metalloproteinase #fibrinogenase #structural characterization #WESTERN DIAMONDBACK RATTLESNAKE #EXOGENOUS HEMOSTATIC FACTORS #BIOCHEMICAL-CHARACTERIZATION #HEMORRHAGIC METALLOPROTEINASE #BOTHROPS-MOOJENI-(CAISSACA) VENOM #STANDARDIZATION COMMITTEE #PRACTICAL APPLICATIONS #INTERNATIONAL SOCIETY #PLATELET-AGGREGATION #PROTEOLYTIC-ENZYME #Pharmacology & Pharmacy #Toxicology
Tipo

article

original article

publishedVersion